Table II.
Comparison of Calculated Latent Amino Acid Side-Chain Coefficients and RP-HPLC-Derived Amino Acid Coefficients
Amino Acid |
Latenta Coeffs. |
Group 1b (-GX-OH) |
Group 2 (-GX-amide) |
Group 3 (Ac-XG-) |
Group 4 (NH3+-XG-) |
Group 5 (-GXG-) |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coeffs.c | Normd | Norm ’e | Δ f | Coeffs. | Norm | Norm ’ | Δ | Coeffs. | Norm | Norm ’ | Δ | Coeffs. | Norm | Norm ’ | Δ | Coeffs. | Norm | Norm ’ | Δ | ||
Trp | 100.00 | 40.0 | 100.00 | 94.49 | −5.51 | 36.5 | 100.00 | 100.98 | 0.98 | 33.2 | 100.00 | 100.77 | 0.77 | 27.9 | 100.00 | 114.50 | 14.50 | 22.9 | 100.00 | 101.14 | 1.14 |
Phe | 90.17 | 37.0 | 92.98 | 87.71 | −2.46 | 32.9 | 90.24 | 91.30 | 1.13 | 29.6 | 89.42 | 90.17 | 0.00 | 22.3 | 80.13 | 92.23 | 2.06 | 20.6 | 91.00 | 91.61 | 1.44 |
Leu | 73.84 | 32.2 | 81.75 | 76.84 | 3.00 | 26.0 | 71.52 | 72.74 | −1.10 | 23.7 | 72.09 | 72.80 | −1.04 | 15.8 | 57.07 | 66.37 | −7.47 | 16.8 | 76.13 | 75.86 | 2.02 |
Ile | 69.53 | 30.5 | 77.77 | 73.00 | 3.47 | 25.2 | 69.35 | 70.59 | 1.06 | 21.8 | 66.51 | 67.20 | −2.33 | 14.2 | 51.39 | 60.01 | −9.52 | 15.3 | 70.26 | 69.65 | 0.12 |
Met | 51.64 | 21.2 | 56.00 | 51.95 | 0.31 | 18.0 | 49.82 | 51.22 | −0.42 | 16.5 | 50.94 | 51.60 | −0.04 | 11.8 | 42.87 | 50.46 | −1.18 | 11.2 | 54.22 | 52.66 | 1.02 |
Tyr | 47.49 | 18.9 | 50.62 | 46.74 | −0.75 | 16.4 | 45.48 | 46.92 | −0.57 | 15.6 | 48.30 | 48.95 | 1.46 | 12.8 | 46.42 | 54.44 | 6.95 | 8.2 | 42.48 | 40.23 | −7.26 |
Val | 44.60 | 20.0 | 53.19 | 49.23 | 4.63 | 15.4 | 42.77 | 44.23 | −0.37 | 13.8 | 43.01 | 43.65 | −0.95 | 8.1 | 29.74 | 35.74 | −8.86 | 8.6 | 44.04 | 41.89 | −2.71 |
Pro | 27.54 | 12.2 | 34.94 | 31.58 | 4.04 | 7.5 | 21.34 | 22.97 | −4.57 | 10.2 | 32.43 | 33.05 | 5.51 | 4.5 | 16.97 | 21.42 | −6.12 | 3.6 | 24.48 | 21.17 | −6.37 |
Cys | 26.84 | 10.8 | 31.66 | 28.41 | 1.57 | 8.6 | 24.33 | 25.93 | −0.91 | 8.1 | 26.26 | 26.87 | 0.03 | 4.3 | 16.26 | 20.63 | −6.21 | 6.0 | 33.87 | 31.12 | 4.28 |
Ala | 13.26 | 5.0 | 18.09 | 15.29 | 2.03 | 3.0 | 9.14 | 10.87 | −2.39 | 3.4 | 12.46 | 13.03 | −0.23 | 1.5 | 6.32 | 9.49 | −3.77 | 2.8 | 21.35 | 17.86 | 4.60 |
Glu | 11.12 | 2.1 | 11.30 | 8.73 | −2.39 | 3.8 | 11.31 | 13.02 | 1.90 | 3.1 | 11.58 | 12.15 | 1.03 | 1.4 | 5.97 | 9.09 | −2.03 | 2.3 | 19.39 | 15.79 | 4.67 |
Thr | 11.64 | 3.6 | 14.81 | 12.12 | 0.48 | 3.3 | 9.95 | 11.68 | 0.04 | 2.8 | 10.69 | 11.26 | −0.38 | 1.9 | 7.74 | 11.08 | −0.56 | 1.5 | 16.26 | 12.47 | 0.83 |
Arg | 10.24 | 2.5 | 12.23 | 9.63 | −0.61 | 3.7 | 11.04 | 12.75 | 2.51 | 2.4 | 9.52 | 10.09 | −0.15 | 3.0 | 11.65 | 15.46 | 5.22 | −1.1 | 6.09 | 1.70 | −8.54 |
Asp | 8.15 | 1.4 | 9.66 | 7.14 | −1.01 | 1.9 | 6.15 | 7.91 | −0.24 | 1.7 | 7.46 | 8.03 | −0.12 | 1.4 | 5.97 | 9.09 | 0.94 | 1.5 | 16.26 | 12.47 | 4.32 |
Gln | 6.00 | 0.0 | 6.38 | 3.97 | −2.03 | 1.6 | 5.34 | 7.10 | 1.10 | 0.7 | 4.53 | 5.08 | −0.92 | 1.4 | 5.97 | 9.09 | 3.09 | 0.8 | 13.52 | 9.57 | 3.57 |
Gly | 3.80 | 0.0 | 6.38 | 3.97 | 0.17 | 0.0 | 1.00 | 2.80 | −1.00 | 0.0 | 2.47 | 3.02 | −0.78 | 0.0 | 1.00 | 3.52 | −0.28 | 0.0 | 10.39 | 6.26 | 2.46 |
His | 4.14 | 0.0 | 6.38 | 3.97 | −0.17 | 1.2 | 4.25 | 6.03 | 1.89 | 0.0 | 2.47 | 3.02 | −1.12 | 1.4 | 5.97 | 9.09 | 4.95 | −2.4 | 1.00 | −3.68 | −7.82 |
Ser | 3.53 | −0.8 | 4.51 | 2.16 | −1.37 | 0.0 | 1.00 | 2.80 | −0.73 | 0.0 | 2.47 | 3.02 | −0.51 | 0.0 | 1.00 | 3.52 | −0.01 | 0.6 | 12.74 | 8.74 | 5.21 |
Lys | 2.92 | −1.0 | 4.04 | 1.71 | −1.21 | 0.0 | 1.00 | 2.80 | −0.12 | −0.3 | 1.59 | 2.14 | −0.78 | 1.3 | 5.61 | 8.69 | 5.77 | −2.3 | 1.39 | −3.27 | −6.19 |
Asn | 1.00 | −2.3 | 1.00 | −1.23 | −2.23 | 0.0 | 1.00 | 2.80 | 1.80 | −0.5 | 1.00 | 1.55 | 0.55 | 0.0 | 1.00 | 3.52 | 2.52 | −0.5 | 8.43 | 4.19 | 3.19 |
Aveg | Ave. | Ave. | Ave. | Ave. | |||||||||||||||||
1.97 | 1.24 | 0.94 | 4.60 | 3.89 |
Calculated coefficients derived from the five peptide groups shown in Table I by latent regression modeling (see Computational Methods for details).
The sequences of peptide Groups 1-5 are shown in Table I.
Peptide mixtures were eluted from a Kromasil C18 column (150 × 2.1 mm I.D., 5 μm particle size, 100 Å pore size) by a linear AB gradient (0.25% B/min) at a flow-rate of 0.3 ml/min and a temperature of 25°C, where eluent A was 20 mM aq. TFA containing 2% (v/v) acetonitrile and eluent B was 20 mM TFA in acetonitrile; coefficients were subsequently expressed as peptide retention time relative to the Gly-substituted peptide for that sequence.
Coefficient normalization was achieved by assigning a value of 100 and 1, respectively, to the highest and lowest RP-HPLC derived coefficients, thus being consistent with the approach to calculation of the latent coefficients.
Norm ’ denotes adjustment of the normalized coefficients of all five peptide groups to achieve a slope of 1.0 and an intercept of zero when plotted against the calculated latent coefficients (Figure 2C).
Δ denotes deviation of RP-HPLC-derived coefficients (Norm ’ values) and calculated latent coefficients.
Average of absolute Δ values.